Drug intelligence / Profile preview

ProBion Basic

Development stage: Unknown
Lead developer: Wasa Medicals
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

ProBion Basic is a probiotic dietary supplement developed and manufactured by Wasa Medicals AB, a Swedish company. It is specifically formulated for individuals with sensitive, slow, or constipated digestion, and is also intended to support those with irritable bowel syndrome (IBS) and lactose intolerance. The supplement contains a blend of live bacterial strains, including *Bifidobacterium lactis* BL04, *Lactobacillus plantarum* LP115, and *Lactobacillus bulgaricus* LB87, providing 4 billion CFU per tablet. A key feature of the product is the proprietary ProBion Matrix Technology, which utilizes a sustained-release formulation to deliver the probiotics to the gastrointestinal tract over a period of 150-180 minutes. The product is free from common allergens such as dairy, soy, wheat, and gluten, and is suitable for vegans, pregnant women, and all age groups.

Brand names: ProBion Basic

Beyond the preview

Go deeper on ProBion Basic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProBion Basic.

Explore the full profile